7.69
+0.38(+5.20%)
Currency In USD
| Previous Close | 7.31 |
| Open | 7.38 |
| Day High | 7.81 |
| Day Low | 7.2 |
| 52-Week High | 10.08 |
| 52-Week Low | 1.86 |
| Volume | 2.89M |
| Average Volume | 3.18M |
| Market Cap | 645M |
| PE | -13.03 |
| EPS | -0.59 |
| Moving Average 50 Days | 6.96 |
| Moving Average 200 Days | 5.37 |
| Change | 0.38 |
If you invested $1000 in ASP Isotopes Inc. Common Stock (ASPI) since IPO date, it would be worth $2,880.15 as of June 25, 2025 at a share price of $7.69. Whereas If you bought $1000 worth of ASP Isotopes Inc. Common Stock (ASPI) shares 2 years ago, it would be worth $16,027.51 as of June 25, 2025 at a share price of $7.69.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC (QLE) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE
GlobeNewswire Inc.
Jun 11, 2025 12:23 PM GMT
WASHINGTON , June 11, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multip
ASP Isotopes Inc. to host Investor Access Event in South Africa from June 16-18, 2025
GlobeNewswire Inc.
Jun 04, 2025 1:00 PM GMT
WASHINGTON, June 04, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multipl
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
GlobeNewswire Inc.
Jun 04, 2025 12:30 PM GMT
- Gadolinium-160 is a critical precursor isotope for producing Terbium-161, an emerging medical isotope with significant potential in targeted radiotherapies. - Supply agreement is for four years’ supply of enriched Gd-160, commencing in 2026, with a